To better understand what causes diabetic foot ulcers, researchers using a leading-edge technology known as single-cell RNA-sequencing analysis had mapped the cellular landscape in diabetic foot ulcers of healers and non-healers.
To better understand what causes diabetic foot ulcers, researchers using a leading-edge technology known as single-cell RNA-sequencing analysis had mapped the cellular landscape in diabetic foot ulcers of healers and non-healers. The study conducted by Beth Israel Deaconess Medical Center (BIDMC) researchers provides deep insight into cell function and disease development by revealing gene expression in individual cells in tissues comprised of various cell types.
‘Diabetic foot ulcerations – open sores or wounds that refuse to heal – are a devastating complication affecting more than 15 percent of people with diabetes and resulting in more than 70,000 lower extremity amputations per year in the United States alone.’
“Various cell types, including endothelial cells, fibroblasts, keratinocytes and immune cells, play an important role in the wound healing process but little is understood about their involvement in impaired wound healing in diabetic foot ulcers,” said co-corresponding author Aristidis Veves, DSc, MD, director of the Rongxiang Xu, MD, Center for Regenerative Therapeutics and research director of the Joslin-Beth Israel Deaconess Foot Center. “We have now substantially expanded the number of cells sequenced and gained novel insights into diabetic foot ulcers. Our data suggests that specific fibroblast subtypes are key players in healing these ulcers and targeting these cells could be one therapeutic option. While further testing is needed, our data set will be a valuable resource for diabetes, dermatology and wound healing research and can serve as the baseline for designing experiments for the assessment of therapeutic interventions.”
This work was funded in part by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). To see a complete list of funders, coauthors, and disclosures, read the full study published in Nature Communications.
About Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School and consistently ranks as a national leader among independent hospitals in National Institutes of Health funding. BIDMC is the official hospital of the Boston Red Sox.
Advertisement
Source-Eurekalert